Abstract

Src is a protein tyrosine kinase commonly activated downstream of transmembrane receptors and plays key roles in cell growth, migration and survival signaling pathways. In conventional dendritic cells (cDCs), Src is involved in the activation of the non-enzymatic functions of indoleamine 2,3-dioxygenase 1 (IDO1), an immunoregulatory molecule endowed with both catalytic activity and signal transducing properties. Prompted by the discovery that the metabolite spermidine confers a tolerogenic phenotype on cDCs that is dependent on both the expression of IDO1 and the activity of Src kinase, we here investigated the spermidine mode of action. We found that spermidine directly binds Src in a previously unknown allosteric site located on the backside of the SH2 domain and thus acts as a positive allosteric modulator of the enzyme. Besides confirming that Src phosphorylates IDO1, here we showed that spermidine promotes the protein-protein interaction of Src with IDO1. Overall, this study may pave the way toward the design of allosteric modulators able to switch on/off the Src-mediated pathways, including those involving the immunoregulatory protein IDO1.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting file.Figure 1 - Source Data 1; Figure 1 - Source Data 2; Figure 1 - Figure supplement 1 - Source Data 3; Figure 2 - Source Data 4; Figure 2 - Figure supplement 1 - Source Data 5; Figure 2 - Figure supplement 2 - Source Data 6; Figure 3 - Source Data 7; Figure 3 - Source Data 8; Figure 3 - Source Data 9; Figure 3 - Source Data 10; Figure 3 - Source Data 11; Figure 3 - Figure supplement 1 - Source Data 12: contain the original blots used to generate the figures.

Article and author information

Author details

  1. Sofia Rossini

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  2. Marco Gagaro

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Giulia Scalisi

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Elisa Bianconi

    Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4597-8056
  5. Sara Ambrosino

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Eleonora Panfili

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Claudia Volpi

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  8. Ciriana Orabona

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  9. Antonio Macchiarulo

    Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  10. Francesca Fallarino

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  11. Giada Mondanelli

    Department of Medicine and Surgery, University of Perugia, Perugia, Italy
    For correspondence
    giada.mondanelli@unipg.it
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0798-0465

Funding

Università degli Studi di Perugia (Ricerca di base 2019)

  • Giada Mondanelli

Associazione italiana per la ricerca sul cancro (AIRC 2019-23084)

  • Claudia Volpi

Italian Ministry of Education, University, and Research (PRIN 2020L45ZW)

  • Ciriana Orabona

Università degli Studi di Perugia (Ricerca di base 2020)

  • Antonio Macchiarulo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Rossini et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 707
    views
  • 118
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sofia Rossini
  2. Marco Gagaro
  3. Giulia Scalisi
  4. Elisa Bianconi
  5. Sara Ambrosino
  6. Eleonora Panfili
  7. Claudia Volpi
  8. Ciriana Orabona
  9. Antonio Macchiarulo
  10. Francesca Fallarino
  11. Giada Mondanelli
(2023)
A back-door insights into the modulation of Src kinase activity by the polyamine spermidine
eLife 12:e85872.
https://doi.org/10.7554/eLife.85872

Share this article

https://doi.org/10.7554/eLife.85872

Further reading

    1. Biochemistry and Chemical Biology
    Daljit Sangar, Elizabeth Hill ... Jan Bieschke
    Research Article

    Prions replicate via the autocatalytic conversion of cellular prion protein (PrPC) into fibrillar assemblies of misfolded PrP. While this process has been extensively studied in vivo and in vitro, non-physiological reaction conditions of fibril formation in vitro have precluded the identification and mechanistic analysis of cellular proteins, which may alter PrP self-assembly and prion replication. Here, we have developed a fibril formation assay for recombinant murine and human PrP (23-231) under near-native conditions (NAA) to study the effect of cellular proteins, which may be risk factors or potential therapeutic targets in prion disease. Genetic screening suggests that variants that increase syntaxin-6 expression in the brain (gene: STX6) are risk factors for sporadic Creutzfeldt-Jakob disease (CJD). Analysis of the protein in NAA revealed, counterintuitively, that syntaxin-6 is a potent inhibitor of PrP fibril formation. It significantly delayed the lag phase of fibril formation at highly sub-stoichiometric molar ratios. However, when assessing toxicity of different aggregation time points to primary neurons, syntaxin-6 prolonged the presence of neurotoxic PrP species. Electron microscopy and super-resolution fluorescence microscopy revealed that, instead of highly ordered fibrils, in the presence of syntaxin-6 PrP formed less-ordered aggregates containing syntaxin-6. These data strongly suggest that the protein can directly alter the initial phase of PrP self-assembly and, uniquely, can act as an 'anti-chaperone', which promotes toxic aggregation intermediates by inhibiting fibril formation.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Birol Cabukusta, Shalom Borst Pauwels ... Jacques Neefjes
    Research Article

    Numerous lipids are heterogeneously distributed among organelles. Most lipid trafficking between organelles is achieved by a group of lipid transfer proteins (LTPs) that carry lipids using their hydrophobic cavities. The human genome encodes many intracellular LTPs responsible for lipid trafficking and the function of many LTPs in defining cellular lipid levels and distributions is unclear. Here, we created a gene knockout library targeting 90 intracellular LTPs and performed whole-cell lipidomics analysis. This analysis confirmed known lipid disturbances and identified new ones caused by the loss of LTPs. Among these, we found major sphingolipid imbalances in ORP9 and ORP11 knockout cells, two proteins of previously unknown function in sphingolipid metabolism. ORP9 and ORP11 form a heterodimer to localize at the ER-trans-Golgi membrane contact sites, where the dimer exchanges phosphatidylserine (PS) for phosphatidylinositol-4-phosphate (PI(4)P) between the two organelles. Consequently, loss of either protein causes phospholipid imbalances in the Golgi apparatus that result in lowered sphingomyelin synthesis at this organelle. Overall, our LTP knockout library toolbox identifies various proteins in control of cellular lipid levels, including the ORP9-ORP11 heterodimer, which exchanges PS and PI(4)P at the ER-Golgi membrane contact site as a critical step in sphingomyelin synthesis in the Golgi apparatus.